Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04626310 · ClinicalTrials.gov registry record · NA
Mapping Aspects of Psychotherapy in Dialectical Behavior Therapy
A NA study, sponsored by University of Massachusetts, Amherst.
- Completed
- Registry status
- NA
- Development phase
- 84
- Enrollment target
NCT04626310: Completed NA study, sponsored by University of Massachusetts, Amherst.
NCT04626310 is a NA study that has completed, run by University of Massachusetts, Amherst. The registered enrollment target is 84 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04626310, a NA study, has completed, sponsored by University of Massachusetts, Amherst.
- COMPLETED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
Study Summary
Although dialectical behavior therapy (DBT) skills training is effective in the treatment of borderline personality disorder, it contains four skills modules and there is little research to guide their modular application. This study compares the unique effects of two distinct DBT skills training modules, relative to a non-DBT therapy group for adults with borderline personality disorder. Using innovative laboratory-based assessment methods, the proposed study will examine the effects of these conditions on emotional responding and interpersonal functioning, as well as clinical outcomes.
Primary Outcome
Assessed with the Difficulties in Emotion Regulation Scale (DERS), which has total scores that range from 36-180, with higher scores indicating more difficulties. Outcomes are reported as slopes (scores over weeks, centered around the start of treatment, with standard errors) per condition, extracted from mixed effects/multilevel models. This measure is listed separately to permit presentation of two units of measure (that are in the same model) - the Linear unit of measure (DERS scores/week), a
Interventions
- BEHAVIORAL Dialectical behavior therapy - emotion regulation skills training
- BEHAVIORAL Dialectical behavior therapy - interpersonal effectiveness skills training
- BEHAVIORAL Interpersonal psychotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2020-10-26 |
| Est. Completion | 2023-02-06 |
| Phase | NA |
What the finished NCT04626310 record still lists
NCT04626310 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 3 interventions - of which Dialectical behavior therapy - emotion regulation skills training is the first listed.
NCT04626310 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04626310 about?
NCT04626310 is a clinical study titled "Mapping Aspects of Psychotherapy in Dialectical Behavior Therapy". Although dialectical behavior therapy (DBT) skills training is effective in the treatment of borderline personality disorder, it contains four skills modules and there is little research to guide their modular application. This study compares the unique effects of two distinct DBT skills training mo...
What is the current status of trial NCT04626310?
This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2020-10-26. Estimated completion is 2023-02-06.
What interventions are being tested in trial NCT04626310?
The interventions under investigation include: Dialectical behavior therapy - emotion regulation skills training (BEHAVIORAL), Dialectical behavior therapy - interpersonal effectiveness skills training (BEHAVIORAL), Interpersonal psychotherapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT04626310?
This trial is sponsored by University of Massachusetts, Amherst, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04626310's enrollment target sits among peer trials
84 983rd of 2000 higher than 1,011 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI